NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Saturday, November 21, 2009 6:22 AM

melanoma

Type: Keyphrase

Name: melanoma

First Reported 17 hours ago - Updated 5 hours ago - 5 Documents

Genta Incorporated (GETA.OB)'s Genasense(R) Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Genta Incorporated (OTCBB: GETA.OB) announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Companyâs lead oncology product, ... [BioSpace - 5 hours ago]

Entities: Genta Incorporated, melanoma, Infusion, Chemotherapy

First Reported 11/19/2009 - Updated 11/20/2009 - 2 Documents (in Medicine)

Skin cancer campaign targets youth

A new $1 million campaign targeting 15 to 24-year-olds in Victoria is urging a rethink on the myth that a tan is healthy.A new $1 million campaign targeting 15 to 24-year-olds was launched at the Cancer Council on Thursday to highlight the damaging effects ... [Sky News Australia - 11/20/2009]

Entities: Skin Cancer, melanoma, Peter MacCallum, basal cell

First Reported 11/20/2009 - Updated 22 hours ago - 3 Documents (in Medicine)

Laser therapy worsens skin cancer: Study

High irradiances of low-level laser therapy (LLLT) can worsen skin cancer, and thus should not be used over melanomas, say researchers.Researchers from Bergen University College, Norway, studied the pain relieving, anti-inflammatory 'cold laser', finding ... [Sify - 22 hours ago]

Entities: laser therapy, Skin Cancer, Bergen University College, Irradiation, Tumor

First Reported 11/19/2009 - Updated 11/19/2009 - 4 Documents (in Medicine)

Recent progress of Delcath Systems in drug delivery platform reported

Active negotiations continue with several international entities to provide exclusive geographic market rights for the PHP System.In early September, the Data and Safety Monitoring Board ('DSMB') reviewed clinical data on 77 patients enrolled in Delcath's ... [News-Medical.Net - 11/19/2009]

Entities: Delcath Systems Incorporated, Metastatic, melphalan

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents

Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma

News From the FieldSourceNYU Langone Medical Center / New York University School of MedicineThe National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. ... [National Science Foundation - 11/19/2009]

Entities: melanoma, NYU Langone Medical Center, New York University School of Medicine

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Internet & IT)

Biocompatibles acquires Astron's melanoma detection devices

U.K. firm Biocompatibles paid Astron Clinica $335,670 to acquire its assets related to MoleMate and MoleView, noninvasive systems used for melanoma detection. The deal will help Biocompatibles bolster its cancer products unit.Clinica (subscription required)| ... [SmartBrief - 11/19/2009]

Entities: melanoma, Medical Devices, Health Care

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents

US Researchers Target New Tumour Treatment

US oncology researchers Champions Biotechnology, Yale University and the Southern Research Institute have established an exclusive licensing agreement to develop Bithionol as a powerful new candidate to treat cancer.The treatment created interest after ... [Pharmaceutical Technology - 11/19/2009]

Entities: Tumor, Net Resources International, Yale University, Southern Research Institute

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents

Piper Jaffray Upgrades Myriad Pharmaceuticals (MYRX) to Neutral

More News related to MYRXMore News related to UpgradesPiper Jaffray & Co. upgrades Myriad Pharmaceuticals (Nasdaq: MYRX) from Underweight to Neutral. Price target increased from $3.50 to $5.00.Piper analyst says, "Yesterday, Myriad Pharmaceuticals updated ... [Street Insider - 11/19/2009]

Entities: Piper Jaffray & Co, melanoma, Metastatic, glioblastoma

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents

Viralytics share price soars on heavy trading volume

Sydney-based anti-cancer biotechnology company Viralytics (ASX: VLA, OTC: VRACY) reported today it was not aware of any information that if known to the market, may cause the increase company’s share price.The shares were up 50%, to $0.041, on trading ... [Proactive Investors.co.uk - 11/19/2009]

Entities: Share Price, melanoma, Financial Services Authority, oncolytic, head and neck cancer

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Medicine)

How to Do a Skin Self-Exam

From the National Cancer Institute publication “What You Need to Know™ About Skin Cancer”Your doctor or nurse may suggest that you do a regular skin self-exam to check for skin cancer, including melanoma.The best time to do this exam is after a shower ... [Cancer Consultants - 11/19/2009]

Entities: Skin Cancer, National Cancer Institute, nevus

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents

Phase II multicenter trial of maintenance biotherapy after induction concurrent biochemotherapy for patients with metastatic melanoma

The response rate to induction biochemotherapy was 44% (95% CI, 35% to 52%; complete response, 8%; partial response, 36%; stable disease, 29%).The median number of biochemotherapy cycles was four, and the median number of maintenance biotherapy cycles ... [MDLinx - 11/19/2009]

Entities: biotherapy, melanoma, Metastatic

First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Corporate Deals)

Biocompatibles buys intellectual property assets from Astron Clinica in £0.2 million deal

Supplier of bead and drug eluting bead products Biocompatibles International (AIM: BII) has acquired the inventory and intellectual property assets of Astron Clinica Limited, which is currently in administration.The acquisition will help Biocompatibles ... [Proactive Investors.co.uk - 11/19/2009]

Entities: Biocompatibles International plc, Intellectual Property, melanoma, Financial Services Authority

Quotes

...Loretta M Itri, Genta's President, . "Temozolomide is the active metabolite of dacarbazine that has been used in our Phase 3 trial in patients with advanced melanoma. I am pleased to confirm that Genta will continue the Phase 3, randomized, double-blind AGENDA trial in order to determine overall survival in that study. Finally, taxanes are being increasingly used in patients with metastatic melanoma. We intend to initiate a Phase 2 study of our proprietary oral taxane, tesetaxel, in advanced melanoma. We hope our comprehensive approach with these new medicines may improve the management of this devastating disease." About the AGENDA trial in advanced melanoma Genta has completed enrollment into AGENDA, a Phase 3, randomized, double-blind, placebo-controlled trial...

Nebulastocks.com : Presents Exciting Picks That Make Astronomical Gains Brings You - Genta Incorp ... [Pharmacy Choice - 8 hours ago]

"LLLT has gained increasing popularity as a treatment for soft tissue injuries and joint conditions. However, there is a shortage of evidence, especially in vivo evidence, about the effects of LLLT in malignant conditions such as melanoma" he said

Laser therapy worsens skin cancer: Study [Sify - 22 hours ago]

More Content

sort by: Date \| Relevance
Scary Things about Health Care Reform [Prevention - 42 mins ago]
Antigenics Inc. (New York) (AGEN) Cancer Vaccin... [BioSpace - 5 hours ago]
Genta Incorporated (GETA.OB)'s Genasense(R) Giv... [BioSpace - 5 hours ago]
Palin biography makes waves [Times Online - 7 hours ago]
Nebulastocks.com : Presents Exciting Picks That... [Pharmacy Choice - 8 hours ago]
Genasense(R) Given as High-Dose IV Infusion wit... [Individual.com - 14 hours ago]
BioMed News Bytes: AstraZeneca, Delcath, Unilife [Seeking Alpha - 15 hours ago]
Genta announces preliminary results from study ... [News-Medical.Net - 15 hours ago]
Genasense(R) Given as High-Dose IV Infusion wit... [Forbes.com - 16 hours ago]
Genasense(R) Given as High-Dose IV Infusion wit... [RBC Dain Rauscher - 17 hours ago]
Biocompatibles buys Astron Clinica [Bio Spectrum Asia - 18 hours ago]
Use of Oral N-Acetylcysteine for Protection of ... [MDLinx - 19 hours ago]
Laser therapy worsens skin cancer: Study [Sify - 22 hours ago]
Low-level laser therapy increases tumour growth... [News-Medical.Net - 11/20/2009]
Special Focus: Cancer Testing: Genetic Signatur... [Laboratory Industry Report - 11/20/2009]
Predicting Who Will Survive Skin Cancer [US News - 11/20/2009]
Laser therapy can aggravate skin cancer [EurekAlert! - 11/20/2009]
Skin cancer campaign targets youth [Sky News Australia - 11/20/2009]
PharmaNet To Conduct Scancell SCIB1 Trial [Contract Pharma - 11/20/2009]
Biocompatibles acquires Astron's melanoma detec... [SmartBrief - 11/19/2009]
BioMed News Bytes: AstraZeneca, Delcath, Unilif... [SocialPicks - 11/19/2009]
Hundreds of Genes Distinguish Patients Likely t... [National Science Foundation - 11/19/2009]
Recent progress of Delcath Systems in drug deli... [News-Medical.Net - 11/19/2009]
Market Report -- In Play (DCTH) [Briefing.com via MSN Money - 11/19/2009]
Piper Jaffray Upgrades Myriad Pharmaceuticals (... [Street Insider - 11/19/2009]
Delcath Systems Reports Substantial Progress [Stockwatch - 11/19/2009]
Delcath Systems Reports Substantial Progress [Yahoo! Canada - 11/19/2009]
US Researchers Target New Tumour Treatment [Pharmaceutical Technology - 11/19/2009]
Viralytics share price soars on heavy trading v... [Proactiveinvestors United Kingdom RSS feed - 11/19/2009]
Biocompatibles buys intellectual property asset... [Proactive Investors.co.uk - 11/19/2009]

Blogs

sort by: Date \| Relevance
And Now We Know How Padma Likes Her Eggs in the... [Gawker - 11/12/2009] newVideoPlayer("/Padma_Bruce_Gaw ... 500, 375,""); Awaken and behold the tale of six chefs, two hearts beating as one, a sad strip, a sassafras dream and a love ...
BioVex Secures Additional $30M to Complete Canc... [alarm:clock euro - 11/11/2009] BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, has concluded $70M (€46M) in private ...
BioMed News: Rockwell Medical, EXACT Sciences, ... [Biotech Sector and Stocks Analysis from Seeking ... - 10/30/2009] Mike Havrilla submits:The BioMedReports.com FDA Calendar service includes a database with over 400 entries of (1) pending new drug, biological agent, or medical ...
Earnings Preview: Celgene [Biotech Sector and Stocks Analysis from Seeking ... - 10/21/2009] Celgene (CELG) is expected to report Q3 earnings Thursday, October 22 before market open, with a conference call scheduled for 9:00 am ET. GuidanceAnalysts are ...
HPV vaccinination---this is real, people [White... [ScienceBlogs : Combined Feed - 10/14/2009] First let me remind you that I've written extensively about HPV infection, cervical cancer, and Gardasil, the vaccine to prevent these. The links are at the bottom ...

Audio/Video

sort by: Date \| Relevance
VIDEO: Laser Therapy Worsens Skin Cancer, Pregn... [Mefeedia Video Tag : canc - 11/19/2009]
Screen Saver? [Slate Magazine - 11/17/2009]
When it comes to cancer screening, more isn't a... [Slate Magazine - 11/17/2009]
High Impact Science - BRAF [Cancer Research UK - YouTube Channel - 08/24/2009]
UK RESEARCH ON MELANOMA CANCER [Mefeedia Video Tag : canc - 07/20/2009]

Change Password

Log in to Silobreaker

Advanced Search Options

melanoma